Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients

The novel coronavirus infection has spread worldwide, causing a wide spectrum of clinical manifestations. Most patients develop moderate clinical illness, but a substantial number will experience severe pneumonia, which may rapidly progress to acute respiratory distress syndrome and multiple organ f...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalkias, Athanasios, Mouzarou, Angeliki, Samara, Evangelia, Xanthos, Theodoros, Ischaki, Eleni, Pantazopoulos, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327460/
https://www.ncbi.nlm.nih.gov/pubmed/32613288
http://dx.doi.org/10.1007/s40291-020-00481-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327460/
https://www.ncbi.nlm.nih.gov/pubmed/32613288
http://dx.doi.org/10.1007/s40291-020-00481-8

Ejemplares similares